|
|
Sarcoglycan in Myopathy and Muscle Membrane Stability |
| 5 R01 HL061322-22 |
|
NHLBI |
2021 |
|
|
Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy |
| 5 R01 HL119371-08 |
|
NHLBI |
2021 |
|
|
Noradrenergic mechanisms in breathing and respiratory pathophysiologies |
| 5 R01 HL130249-07 |
|
NHLBI |
2021 |
|
|
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation |
| 5 R01 HL139065-37 |
|
NHLBI |
2021 |
|
|
Regulating fibrosis and growth through latent TGFbeta binding proteins |
| 5 R01 HL140938-04 |
|
NHLBI |
2021 |
|
|
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY |
| 5 R01 HL146436-03 |
|
NHLBI |
2021 |
|
|
Molecular basis of telomere dysfunction in cardiac dystrophy |
| 5 R01 HL146662-03 |
|
NHLBI |
2021 |
|
|
Cardiotoxicity in Total Joint Arthroplasty |
| 5 R01 HL147155-03 |
|
NHLBI |
2021 |
|
|
Final Pre-clinical Studies for a Ventricular Assist Device for Infants |
| 5 R01 HL151736-02 |
|
NHLBI |
2021 |
|
|
Combinatorial Approaches to Improved Blood-contacting Polymer Biomaterials |
| 5 R01 HL153231-02 |
|
NHLBI |
2021 |
